These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6373157)

  • 1. Does oxpentifylline ('Trental') have a place in the treatment of intermittent claudication?
    Donaldson DR; Hall TJ; Kester RC; Ramsden CW; Wiggins PA
    Curr Med Res Opin; 1984; 9(1):35-40. PubMed ID: 6373157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent claudication: a double-blind crossover trial of pentoxifylline.
    Gallus AS; Gleadow F; Dupont P; Walsh J; Morley AA; Wenzel A; Alderman M; Chivers D
    Aust N Z J Med; 1985 Aug; 15(4):402-9. PubMed ID: 3866536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs.
    Strano A; Davi G; Avellone G; Novo S; Pinto A
    Angiology; 1984 Jul; 35(7):459-66. PubMed ID: 6380350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment of intermittent claudication.
    Porter JM; Bauer GM
    Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pentoxifylline on severe intermittent claudication.
    Reich T; Gillings D
    Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trental 400 in the treatment of intermittent claudication: results of long-term, placebo-controlled administration.
    Roekaerts F; Deleers L
    Angiology; 1984 Jul; 35(7):396-406. PubMed ID: 6380348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the assessment of the efficacy of pentoxifylline (Trental).
    Rössner M; Müller R
    J Med; 1987; 18(1):1-15. PubMed ID: 3298515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of oxpentifylline ('Trental') on fibrinolytic activity and plasma fibrinogen levels.
    Jarret PE; Moreland M; Browse NL
    Curr Med Res Opin; 1977; 4(7):492-5. PubMed ID: 321184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?
    Johnson WC; Sentissi JM; Baldwin D; Hamilton J; Dion J
    J Vasc Surg; 1987 Sep; 6(3):211-6. PubMed ID: 3625877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients.
    Porter JM; Cutler BS; Lee BY; Reich T; Reichle FA; Scogin JT; Strandness DE
    Am Heart J; 1982 Jul; 104(1):66-72. PubMed ID: 7046409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 16. Pentoxifylline (Trental)--a new drug for the treatment of peripheral chronic occlusive arterial disease.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    J Med; 1988; 19(2):89-107. PubMed ID: 3049876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline and intermittent claudication.
    Spittel JA
    Ann Intern Med; 1985 Jan; 102(1):126-7. PubMed ID: 3966730
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
    Perego MA; Sergio G; Artale F; Giunti P; Danese C
    Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication.
    Di Perri T; Guerrini M
    Angiology; 1983 Jan; 34(1):40-5. PubMed ID: 6824189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined intravenous and oral pentoxifylline in the treatment of peripheral vascular disease. A clinical trial.
    Thomson GJ; Thomson S; Todd AS; Vohra RK; Carr MH; Walker MG
    Int Angiol; 1990; 9(4):266-70. PubMed ID: 2099961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.